lissamine rhodamine b has been researched along with Neoplasms in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (40.00) | 29.6817 |
2010's | 8 (53.33) | 24.3611 |
2020's | 1 (6.67) | 2.80 |
Authors | Studies |
---|---|
Chauhan, RP; Jain, S; Kaul, A; Mathur, R; Mishra, AK; Singh, G; Singh, S; Varshney, R | 1 |
Fallon, JK; He, Z; Liu, D; Liu, F; Ma, Y; Wang, D; Wang, Y; Xu, XE; Yang, X; Zhao, Q | 1 |
Gunaratnam, M; Neidle, S | 1 |
Barthel, A; Csuk, R; Schwarz, S; Sczepek, R; Siewert, B | 1 |
Martin, S; Woolston, C | 1 |
Choi, SU; Kim, KH; Lee, IK; Lee, JH; Lee, KR; Lee, SY; Park, CH | 1 |
Csuk, R; Kluge, R; Schwarz, S; Siewert, B; Ströhl, D | 1 |
Barthel, A; Csuk, R; Heinold, A; Kluge, R; Schwarz, S; Siewert, B; Ströhl, D | 1 |
Gang, SS; Hariharapura, RC; Jagani, HV; Josyula, VR; Palanimuthu, VR | 1 |
Alley, MC; Bradshaw, TD; Brantley, E; Hose, CD; Sausville, EA; Stevens, MF; Stinson, SF; Trapani, V | 1 |
Ahmad, I; Ahmad, MU; Ali, SM; Carbonaro, D; Chien, PY; Lei, S; Miller, B; Sheikh, S; Wang, J | 1 |
Houghton, P; Lee, CC | 1 |
Fang, R; Houghton, P; Hylands, PJ; Lee, CC; Steventon, G; Techatanawat, I | 1 |
Comijn, E; De Marco, C; Peters, GJ; Tesei, A; Zaffaroni, N; Zoli, W | 1 |
Chitambar, CR; Dunstan, H; Efferth, T; Miyachi, H; Sauerbrey, A | 1 |
15 other study(ies) available for lissamine rhodamine b and Neoplasms
Article | Year |
---|---|
Tryptophan conjugated magnetic nanoparticles for targeting tumors overexpressing indoleamine 2,3 dioxygenase (IDO) and L-type amino acid transporter.
Topics: A549 Cells; Amino Acids; Animals; Biological Transport; Cell Line, Tumor; Ferric Compounds; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kinetics; Magnetic Resonance Spectroscopy; Magnetite Nanoparticles; MCF-7 Cells; Mice; Microscopy, Electron, Transmission; Nanomedicine; Neoplasms; Rabbits; Radionuclide Imaging; Rhodamines; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Technetium; Tryptophan | 2020 |
Theranostic nanoemulsions: codelivery of hydrophobic drug and hydrophilic imaging probe for cancer therapy and imaging.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Carriers; Humans; Hydrophobic and Hydrophilic Interactions; Mice, Nude; Nanomedicine; Neoplasms; Paclitaxel; Rhodamines; Vitamin E | 2014 |
An evaluation cascade for G-quadruplex telomere targeting agents in human cancer cells.
Topics: Base Sequence; beta-Galactosidase; Biocatalysis; Biological Products; Cell Line, Tumor; Cell Proliferation; DNA; Enzyme Inhibitors; Fluorescence Resonance Energy Transfer; G-Quadruplexes; Humans; Inhibitory Concentration 50; Neoplasms; Rhodamines; Staining and Labeling; Telomerase; Telomere; Time Factors | 2010 |
Synthesis, encapsulation and antitumor activity of new betulin derivatives.
Topics: Antineoplastic Agents; Betulinic Acid; Cell Line, Tumor; Colorimetry; Drug Screening Assays, Antitumor; Fluorescent Dyes; Humans; Liposomes; Neoplasms; Pentacyclic Triterpenes; Pyrazoles; Rhodamines; Structure-Activity Relationship; Triazoles; Triterpenes | 2011 |
Analysis of tumor and endothelial cell viability and survival using sulforhodamine B and clonogenic assays.
Topics: Cell Count; Cell Proliferation; Cell Survival; Colony-Forming Units Assay; Colorimetry; Endothelial Cells; Humans; Neoplasms; Rhodamines; Staining and Labeling; Tissue Fixation | 2011 |
Phenolic constituents of Acorus gramineus.
Topics: Acorus; Allylbenzene Derivatives; Anisoles; Cell Line, Tumor; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Neoplasms; Phenols; Phytotherapy; Plant Extracts; Rhizome; Rhodamines; Stereoisomerism | 2011 |
Conversions at C-30 of glycyrrhetinic acid and their impact on antitumor activity.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Colorimetry; Drug Screening Assays, Antitumor; Glycyrrhetinic Acid; Humans; Medicine, Traditional; Mice; Neoplasms; NIH 3T3 Cells; Rhodamines | 2012 |
Synthesis and biological evaluation of antitumor-active arglabin derivatives.
Topics: Antineoplastic Agents; Cell Line, Tumor; Colorimetry; Drug Screening Assays, Antitumor; Humans; Neoplasms; Rhodamines; Sesquiterpenes; Sesquiterpenes, Guaiane; Structure-Activity Relationship | 2012 |
Nanoformulation of siRNA silencing Bcl-2 gene and its implication in cancer therapy.
Topics: Animals; Blotting, Western; Cell Line, Tumor; Coloring Agents; Drug Compounding; Drug Delivery Systems; Electrochemistry; Female; Fluorescent Antibody Technique; Gene Silencing; Genes, bcl-2; Genetic Therapy; Humans; Lactic Acid; Male; Mice; Nanoparticles; Neoplasms; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Reverse Transcriptase Polymerase Chain Reaction; Rhodamines; RNA, Small Interfering; Tetrazolium Salts; Thiazoles; Transfection | 2011 |
Fluorinated 2-(4-amino-3-methylphenyl)benzothiazoles induce CYP1A1 expression, become metabolized, and bind to macromolecules in sensitive human cancer cells.
Topics: Antineoplastic Agents; Aryl Hydrocarbon Hydroxylases; Blotting, Western; Cell Line, Tumor; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1B1; Dose-Response Relationship, Drug; Enzyme Induction; Humans; Indicators and Reagents; Microsomes; Neoplasms; Protein Binding; Reverse Transcriptase Polymerase Chain Reaction; Rhodamines; RNA, Messenger; Tetrazolium Salts; Thiazoles | 2004 |
Novel cationic cardiolipin analogue-based liposome for efficient DNA and small interfering RNA delivery in vitro and in vivo.
Topics: Animals; beta-Galactosidase; Body Weight; Cardiolipins; Cell Line, Tumor; DNA; Genetic Therapy; Humans; Liposomes; Luciferases; Male; Mice; Mice, Inbred BALB C; Neoplasms; Proto-Oncogene Proteins c-raf; Rhodamines; RNA, Small Interfering; Transfection; Transplantation, Heterologous | 2005 |
Cytotoxicity of plants from Malaysia and Thailand used traditionally to treat cancer.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Chromatography, Thin Layer; Drug Screening Assays, Antitumor; Humans; Magnetic Resonance Spectroscopy; Malaysia; Neoplasms; Phytotherapy; Plant Extracts; Plants, Medicinal; Rhodamines; Spectrometry, Mass, Electrospray Ionization; Spectrometry, Mass, Fast Atom Bombardment; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Thailand | 2005 |
The sulphorhodamine (SRB) assay and other approaches to testing plant extracts and derived compounds for activities related to reputed anticancer activity.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cells, Cultured; Drug Screening Assays, Antitumor; Fluorescent Dyes; Glutathione Transferase; Humans; Molecular Structure; Neoplasms; Plants, Medicinal; Prodrugs; Rhodamines; Up-Regulation | 2007 |
Comparative evaluation of C1311 cytotoxic activity and interference with cell cycle progression in a panel of human solid tumour and leukaemia cell lines.
Topics: Aminoacridines; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; CDC2 Protein Kinase; Cell Division; Cell Proliferation; Cyclin B; Cyclin B1; Doxorubicin; Drug Therapy, Combination; G2 Phase; Humans; Immunoblotting; Immunoprecipitation; Neoplasms; Paclitaxel; Rhodamines; Tumor Cells, Cultured | 2007 |
The anti-malarial artesunate is also active against cancer.
Topics: Antimalarials; Antineoplastic Agents; Artemisinins; Artesunate; Cell Cycle Proteins; Cell Division; Cyclin G; Cyclin G1; Cyclins; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Fluorescent Dyes; Humans; Leukemia; Neoplasms; Poly-ADP-Ribose Binding Proteins; Proteins; Rhodamines; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Sesquiterpenes; Tripeptidyl-Peptidase 1; Tumor Cells, Cultured | 2001 |